Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A GABAergic neuron is any neuron that synthesizes and releases gamma-aminobutyric acid (GABA) as its primary neurotransmitter. These cells are found throughout the central nervous system where they provide inhibitory control over neural circuit activity. Their main function is to reduce neuronal excitability through synaptic inhibition mediated primarily by activation of postsynaptic ionotropic (GABAA) and metabotropic (GABAB) receptors. They play essential roles in maintaining excitation-inhibition balance within brain networks; dysfunction contributes to neuropsychiatric conditions including epilepsy, schizophrenia, mood disorders, autism spectrum disorder, and neurodegeneration. Molecularly diverse subtypes exist across brain regions—such as basket cells or chandelier cells—distinguished by gene expression profiles including enzymes like glutamic acid decarboxylase (GAD65, GAD67) required for synthesis of GABA from glutamate. While not themselves direct molecular drug targets in conventional pharmacology pipelines, modulating their function via targeting associated receptors remains central to many neurological therapies. Markers like GAD and VGAT are used to identify GABAergic neurons... Subtype classification is based on gene expression... which reveals functional and cellular heterogeneity. Neurons that produce GABA as their output are called ‘GABAergic’... have chiefly inhibitory action at receptors... Note: For structured pharmacological data collection you should use specific molecular entities such as “gamma-aminobutyric acid A receptor” (“GABAA receptor”) rather than broad cellular classes like “GABA neurons.”
Not applicable directly to the cell type. Drugs modulate: Activation/inhibition of GABAA/GABAB receptors on these neurons and their targets; Modulation of synaptic release/reuptake/metabolism of GABA. Mechanisms include positive allosteric modulation, reuptake inhibition, metabolic inhibition.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABAergic neuron.